by Stacey Hawkins | May 26, 2016 | Immunotherapies
The Race Is On Our last WEEKLY—Hacking the Immune Response—unveiled the science behind CAR-T and TCR, two immunotherapies under the microscope of the mainstream press. The well-deserved media attention highlights the ability of these “living drugs” to recognize and... by Stacey Hawkins | Sep 18, 2014 | Oncology
Programmed cell death is making a name for itself as a pathway in cancer drug development. We asked ourselves: what is this process known as apoptosis and why is it a sought after drug target? Apoptosis is a system that evolved in cells for detecting damage to DNA and...
